How Immunity Impacts Mental Health and Clinical Application

19 Jun 2026
Level 5 - Mountbatten Room
This session is expected to bridge the gap between neuroimmunology and clinical psychiatry, moving beyond the traditional neurotransmitter-only model. Dr. Kharrazian will detail how "primed" microglial cells - the brain's resident immune cells - trigger chronic, low-grade inflammation that manifests as depression, anxiety, and brain fog. The lecture will focus on practical clinical applications using dietary, nutritional, and lifestyle interventions.
Speakers
Datis Kharrazian
Dr Datis Kharrazian, Founder of the Kharrazian Institute, Harvard Medical School-trained Clinical Research Scientist, USA